4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000899243-22-001380
Options or other derivatives
- Director acquired 4,428 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tregoning Kathleen Director | 2022-01-05 | Grant or award · Stock Option (Right to Buy) | +4,428 | $9.03 | $39,985 | 4,428 | D |
Loading xslF345X03/doc4.xml…